Dr. Reddy's management to meet investors in Singapore next week

Dr. Reddy's Laboratories Ltd. announced its participation in an investor conference with Bank of America in Singapore on December 8-9, 2025. The company's management will be present for an in-person group meeting scheduled from 09:00 to 18:00 SGT each day. This engagement falls under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates the disclosure of analyst and institutional investor meetings.

The company emphasized that the schedule is subject to change based on exigencies from investors or Dr. Reddy's Laboratories. This meeting provides an opportunity for Dr. Reddy's management to interact with investor groups, offering insights into the company's performance and future outlook.

The announcement was formally made on December 2, 2025, and signed by K Randhir Singh, company secretary, compliance officer, and head-CSR for Dr. Reddy's Laboratories Limited. The information was provided to the National Stock Exchange of India Ltd., BSE Limited, New York Stock Exchange Inc., and NSE IFSC Ltd.